Virus-inactivated 2-component fibrin glue
US6019993A · kind A · utility
8Cited by
0References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 30, 1995 |
| Grant date | Feb 1, 2000 |
| Priority date | — |
| Expiry date | Nov 30, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L27/225
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A two-component fibrin glue for human application includes a) a component A containing i) a virus-inactivated and concentrated cryoprecipitate that contains fibrinogen, and ii) tranexamic acid or a pharmaceutically acceptable salt, thereof; and b) component B containing a proteolytic enzyme that, upon combination with component A, cleaves, specifically, fibrinogen present in the cryoprecipitate of component A, thereby, effecting a fibrin polymer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.